Form D · Biotechnology

Harmonigenic Corp

Rochester, NY · CIK 0001665528

Offering snapshot reported Feb 22, 2017 · SEC filing

Reported sold
$50K
Offering amount: $350K
Investors reported
1
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Feb 22, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$25K$50KMar 3, 2016: $50,000.00Mar 3, 2016Feb 22, 2017: $50,000.00Feb 22, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 22, 2017Amendment$50,000$0vs Mar 3, 20161SEC filing
Mar 3, 2016Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity, Debt
Exemptions
04
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-258530

Source: Form D, filed Feb 22, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Hill Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
74 Westland Avenue
Rochester, NY, 14618